New Acupotomy Method for Ankylosing Spondylitis
Part of Bones, joints & muscles clinical trials.
This trial tests a new acupuncture-based procedure called acupotomy to help people with ankylosing spondylitis (a condition that causes spine stiffness and pain). The study aims to see if this improved technique reduces pain and improves mobility.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ankylosing spondylitis or axial spondyloarthritis using standard medical criteria
- You are between 18 and 75 years old
- You experience moderate to significant spine pain or stiffness (BASDAI score of 4 or higher on a scale)
- You are not pregnant or breastfeeding
- You do not have severe heart, brain, liver, kidney disease, cancer, or blood clotting problems
- You are able to attend visits and answer questions about your symptoms
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral medication called LNK01001 for adults with active ankylosing spondylitis. It aims to reduce pain, stiffness, and inflammation when standard NSAID treatments no longer help.
This trial is for people with ankylosing spondylitis (a type of arthritis that affects the spine) who are otherwise healthy. It may test a treatment to see if it helps control symptoms, whether your disease is active or stable.
This trial tests whether stem cells from donated bone marrow can reduce inflammation and pain in ankylosing spondylitis, a condition that causes the spine to become stiff and inflamed. Researchers will monitor how safe and effective this treatment is for eligible patients.
This study tests a new medication (called 608) for adults with active ankylosing spondylitis (AS). It aims to see if the drug can reduce AS symptoms and improve quality of life.
This trial tests whether stem cells from umbilical cord can reduce pain and stiffness in people with ankylosing spondylitis (a disease causing spinal inflammation). You may qualify if you have active AS that hasn't responded well to standard treatments.
This study tests whether combining two types of immune-blocking drugs (an IL-17 inhibitor and a TNF inhibitor) works better than either alone for treating ankylosing spondylitis. It is for people whose symptoms are not well controlled with NSAIDs.
Hear when a new Ankylosing Spondylitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.